Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathway.

Jiang WG, Ye L, Ji K, Frewer N, Ji J, Mason MD.

Int J Oncol. 2012 Nov;41(5):1635-42. doi: 10.3892/ijo.2012.1627. Epub 2012 Sep 11.

PMID:
22971748
2.

Impact of Yangzheng Xiaoji on the adhesion and migration of human cancer cells: the role of the AKT signalling pathway.

Ye L, Ji K, Frewer N, Ji J, Jiang WG.

Anticancer Res. 2012 Jul;32(7):2537-43.

PMID:
22753711
3.

Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.

Huang SW, Lien JC, Kuo SC, Huang TF.

Carcinogenesis. 2012 May;33(5):1022-30. doi: 10.1093/carcin/bgs127. Epub 2012 Mar 20.

PMID:
22436611
4.

Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.

Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT.

J Ethnopharmacol. 2012 Jun 1;141(2):721-7. doi: 10.1016/j.jep.2011.08.052. Epub 2011 Sep 3.

PMID:
21911050
5.

Antitumour effects of Yangzheng Xiaoji in human osteosarcoma: the pivotal role of focal adhesion kinase signalling.

Jiang WG, Ye L, Ji K, Ruge F, Wu Y, Gao Y, Ji J, Mason MD.

Oncol Rep. 2013 Sep;30(3):1405-13. doi: 10.3892/or.2013.2586. Epub 2013 Jul 3.

PMID:
23828123
6.

Focal adhesion kinase inhibitors are potent anti-angiogenic agents.

Cabrita MA, Jones LM, Quizi JL, Sabourin LA, McKay BC, Addison CL.

Mol Oncol. 2011 Dec;5(6):517-26. doi: 10.1016/j.molonc.2011.10.004. Epub 2011 Oct 20.

PMID:
22075057
7.

Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.

Baek YY, Cho DH, Choe J, Lee H, Jeoung D, Ha KS, Won MH, Kwon YG, Kim YM.

Eur J Pharmacol. 2012 Jan 15;674(2-3):188-99. doi: 10.1016/j.ejphar.2011.11.022. Epub 2011 Nov 23.

PMID:
22130357
8.

Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.

Fan Y, Peng A, He S, Shao X, Nie C, Chen L.

J Chemother. 2013 Oct;25(5):298-308. doi: 10.1179/1973947813Y.0000000079.

PMID:
24070138
9.
10.

Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.

Stone RL, Baggerly KA, Armaiz-Pena GN, Kang Y, Sanguino AM, Thanapprapasr D, Dalton HJ, Bottsford-Miller J, Zand B, Akbani R, Diao L, Nick AM, DeGeest K, Lopez-Berestein G, Coleman RL, Lutgendorf S, Sood AK.

Cancer Biol Ther. 2014 Jul;15(7):919-29. doi: 10.4161/cbt.28882. Epub 2014 Apr 23.

PMID:
24755674
11.

Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells.

Juan SH, Lee JL, Ho PY, Lee YH, Lee WS.

Eur J Pharmacol. 2006 Jan 13;530(1-2):1-8. Epub 2005 Dec 15.

PMID:
16359657
12.

Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis.

Sulochana KN, Fan H, Jois S, Subramanian V, Sun F, Kini RM, Ge R.

J Biol Chem. 2005 Jul 29;280(30):27935-48. Epub 2005 May 27.

PMID:
15923192
13.

Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer.

Wang N, Wang ZY, Mo SL, Loo TY, Wang DM, Luo HB, Yang DP, Chen YL, Shen JG, Chen JP.

Breast Cancer Res Treat. 2012 Aug;134(3):943-55. doi: 10.1007/s10549-012-1977-9. Epub 2012 Feb 21.

PMID:
22350787
14.

Antiangiogenic properties of cafestol, a coffee diterpene, in human umbilical vein endothelial cells.

Wang S, Yoon YC, Sung MJ, Hur HJ, Park JH.

Biochem Biophys Res Commun. 2012 May 11;421(3):567-71. doi: 10.1016/j.bbrc.2012.04.046. Epub 2012 Apr 14.

PMID:
22525673
15.

An evaluation of the anti-angiogenic effect of the Korean medicinal formula "Sa-mi-yeon-geon-tang" in vitro and in ovo.

Yi JM, Bang OS, Kim NS.

BMC Complement Altern Med. 2015 Mar 5;15:42. doi: 10.1186/s12906-015-0573-z.

PMID:
25887757
16.

Molecular angiogenic events of a two-herb wound healing formula involving MAPK and Akt signaling pathways in human vascular endothelial cells.

Liu CL, Tam JC, Sanders AJ, Ko CH, Fung KP, Leung PC, Harding KG, Jiang WG, Lau CB.

Wound Repair Regen. 2013 Jul-Aug;21(4):579-87. doi: 10.1111/wrr.12055. Epub 2013 Jun 11.

PMID:
23755905
17.

Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway.

Byun HJ, Lee JH, Kim BR, Kang S, Dong SM, Park MS, Lee SH, Park SH, Rho SB.

Microvasc Res. 2012 Nov;84(3):227-34. doi: 10.1016/j.mvr.2012.09.006. Epub 2012 Sep 26.

PMID:
23022044
18.
19.

Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathway.

Wu Y, He L, Zhang L, Chen J, Yi Z, Zhang J, Liu M, Pang X.

J Pharmacol Exp Ther. 2011 Nov;339(2):403-11. doi: 10.1124/jpet.111.181891. Epub 2011 Aug 9.

PMID:
21828260
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk